Literature DB >> 15577452

Differential effects of midazolam and pentylenetetrazole on behavioral repetition and variation.

J Abreu-Rodrigues1, E S Hanna, A P de Mello Cruz, R Matos, Z Delabrida.   

Abstract

The present study investigated the effects of midazolam and pentylenetetrazole upon repeating and varying sequences of responses. Rats were exposed to a multiple schedule with two components. Under the VARY component, water was provided if the current sequence of four responses differed from each of the five previous ones; under the REPEAT component, water delivery was contingent upon a particular four-response sequence. Each component was signaled by specific exteroceptive stimuli. Overall, sequence variability was affected by midazolam, and to a lesser degree, by pentylenetetrazole. With the REPEAT contingency, drug administration increased behavior variation, thus reducing accuracy; with the VARY contingency, behavior variation and accuracy were not altered. These results were explained on the basis of the disruptive effects of both drugs upon the discriminative control exerted by previous responses within a sequence and by exteroceptive stimuli.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15577452     DOI: 10.1097/00008877-200412000-00002

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  3 in total

1.  History effects on induced and operant variability.

Authors:  Alessandra da Silva Souza; Josele Abreu-Rodrigues; Ana Amélia Baumann
Journal:  Learn Behav       Date:  2010-11       Impact factor: 1.986

2.  Varied but not necessarily random: human performance under variability contingencies is affected by instructions.

Authors:  Alessandra S Souza; Thaissa Neves R Pontes; Josele Abreu-Rodrigues
Journal:  Learn Behav       Date:  2012-12       Impact factor: 1.986

3.  An investigation of resurgence of reinforced behavioral variability in humans.

Authors:  Ann Galizio; Jonathan E Friedel; Amy L Odum
Journal:  J Exp Anal Behav       Date:  2020-11-12       Impact factor: 2.215

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.